Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer.

Yu Tian Zhi-Chao LiuHanbo PanHongda ZhuNingyuan ZouLong JiangZiming LiJia HuangYingjie HuQingquan Luo

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)

Perioperative ICB showed promising efficacy in improving pathological response and survival outcomes of resectable non-small cell lung cancer. For patients without major pathologic response after resection followed by preoperative ICB, sequential ICB treatment could be considered.

Keyphrases

patients undergoing
end stage renal disease
locally advanced
cardiac surgery
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
neoadjuvant chemotherapy
squamous cell carcinoma
liver metastases
patient reported outcomes
acute kidney injury